Cargando…
Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
We here investigate the impact of antiviral treatments such as remdesivir on intra-host genomic diversity and emergence of SARS-CoV2 variants in patients with a prolonged course of infection. Sequencing and variant analysis performed in 112 longitudinal respiratory samples from 14 SARS-CoV2-infected...
Autores principales: | Heyer, Andreas, Günther, Thomas, Robitaille, Alexis, Lütgehetmann, Marc, Addo, Marylyn M., Jarczak, Dominik, Kluge, Stefan, Aepfelbacher, Martin, Schulze zur Wiesch, Julian, Fischer, Nicole, Grundhoff, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378267/ https://www.ncbi.nlm.nih.gov/pubmed/36075217 http://dx.doi.org/10.1016/j.xcrm.2022.100735 |
Ejemplares similares
-
SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
por: Brehm, Thomas Theo, et al.
Publicado: (2021) -
Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
por: Woo, Marcel S., et al.
Publicado: (2022) -
Rapid Automated Screening for SARS-CoV-2 B.1.617 Lineage Variants (Delta/Kappa) through a Versatile Toolset of qPCR-Based SNP Detection
por: Nörz, Dominik, et al.
Publicado: (2021) -
Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants
por: Nörz, Dominik, et al.
Publicado: (2022) -
Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
por: Brehm, Thomas Theo, et al.
Publicado: (2022)